Results 21 to 30 of about 463,559 (166)
Zhongguo shiyan zhenduanxue, 2020 目的了解东莞市2015-2018年结核分支杆菌对四种一线抗结核药物的耐药情况以及耐药患者人群分布特征,为制定科学的耐药结核病治疗和预防策略提供依据。方法收集东莞市2015-2018年登记的痰培养阳性的肺结核患者3975例,菌群鉴定为结核分支杆菌的标本进行药敏试验。药敏试验采用比例法,药物敏感试验药物种类包含异烟肼（INH）、利福平（RFP）、链霉素（SM）、乙胺丁醇（EMB）四种一线抗结核药物。结果 3751株结核分枝杆菌对一线抗结核药物总体耐药率为25.70%（964/3751 ...
闫莉 +4 more
doaj
Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
Rare Metals, Volume 45, Issue 2, February 2026.ABSTRACT Chronic inflammatory skin diseases, encompassing immune‐inflammatory conditions and infection‐associated dermatoses, pose significant clinical challenges due to high prevalence, recurrence, and therapeutic resistance, affect over 30% of the global population.
Zehao Lan +5 more
wiley +1 more source
Zhongguo shiyan zhenduanxue, 2021 研究发现,神经内科病区、医院的重症监护病房(ICU)以及神经外科病区等,病原菌耐药率相较于医院病原菌的整体耐药水平要高出许多,与此同时,其高耐药性与多重耐药性(MDROs)等特征也较为明显,在医院多重耐药菌检出率科室中位居前列[1]。在治疗过程中侵入性操作增加了医院多重耐药菌感染的风险[2]。多重耐药菌的流行增加了不良临床结果的发生率,延长了住院时间,提高了医疗成本。因此,降低神经内科重症住院患者多重耐药菌感染的发生率,提高患者的生活质量,已成为临床医护人员重点关注的问题[3 ...
南鹤, 蔡媛媛, 黄丹
doaj
Advances in Elemene Nanodelivery Systems: From Material Design to Disease Treatment
Rare Metals, Volume 45, Issue 2, February 2026.ABSTRACT Elemene (ELE) is a bioactive sesquiterpenoid extracted from traditional Chinese herbs, demonstrating broad‐spectrum antitumor, anti‐inflammatory, and analgesic properties with significant therapeutic potential. However, its clinical utility is constrained by inherent physicochemical limitations, including volatility and hydrophobicity, which ...
Xiao Wang +9 more
wiley +1 more source
Recent Progress in the Development of Metal‐Based Radiosensitizations for Cancer Therapy: A Review
Rare Metals, Volume 45, Issue 1, January 2026.ABSTRACT Radiotherapy (RT) remains an indispensable means in cancer treatment; however, its therapeutic efficacy is often limited by tumor radioresistance and side effect of damage to healthy tissue. The advances in nanotechnology have propelled metal radiosensitizers to forefront of precision medicine.
Xiao‐Xia Wu +12 more
wiley +1 more source
Rare Metals, Volume 45, Issue 1, January 2026.ABSTRACT The escalating issue of drug‐resistant pathogens, largely driven by the overuse of conventional antibiotics, has become a significant global health threat. Developing alternative therapeutic strategies and fabricating natural biological enzyme materials that mimic the high efficiency, selectivity, and mild‐operating conditions of natural ...
Shuai He +11 more
wiley +1 more source
热化疗逆转人肝癌细胞系BEL-7402/ADM多药耐药性的实验研究
Zhongguo shiyan zhenduanxue, 2005 目的 研究热化疗对多药耐药人肝癌细胞系BEL- 74 0 2 /ADM耐药性的影响并探讨相关的机制。方法 通过MTT法测定热化疗对多药耐药人肝癌细胞系BEL -74 0 2 /ADM耐药性影响;利用流式细胞仪检测多药耐药相关基因（MDR）的表达产物P糖蛋白（P- gp）、多药耐药相关蛋白（MRR）、谷胱甘肽转移酶（GSH/GST）的表达。结果 热化疗使多药耐药人肝癌细胞系BEL- 74 0 2 /ADM耐药性降低;P -gp、MRP和GSH/GST的表达均有所下降。结论 ...
王宁, 杨海山, 刘洁, 李玉
doaj
Zhongguo shiyan zhenduanxue, 2021 目的 建立人胃癌耐药细胞,为研究人胃癌耐药细胞的耐药机制以及为耐药肿瘤细胞的治疗提供耐药肿瘤细胞模型。方法 体外培养人胃癌细胞SGC-7901,用50μmol/L顺铂多次反复冲击,对冲击4次和6次的SGC-7901分别检测对顺铂的抑制率和多药耐药基因（MDR）及多药耐药特异基因片段的表达,并计算药物对细胞的半数抑制浓度（IC50）。结果 经4次和6次冲击后,受冲击的SGC-7901胃癌细胞对顺铂的抑制率明显高于亲本细胞,IC50为63.98μmol/L和66.34μmol/L,而亲本细胞SGC ...
刘玉侠 +6 more
doaj
To Ban or Not to Ban: The UK's Hamlet Moment With Farm Antibiotics
Politics &Policy, Volume 53, Issue 6, December 2025.ABSTRACT This article applies the Multiple Streams Framework (MSF) to examine post‐Brexit antimicrobial resistance (AMR) governance in UK agriculture, focusing on the contested regulation of prophylactic antibiotic use in farm animals. The study reveals how Brexit created a structural policy window, yet political and ideological dynamics rendered it ...
George Asiamah
wiley +1 more source
Veterinary Dermatology, Volume 36, Issue 5, Page 621-629, October 2025.Background – Canine superficial bacterial folliculitis (SBF) is a common recurrent condition with a growing requirement for culture and susceptibility as a consequence of increased antimicrobial resistance and antimicrobial stewardship. Different opinions persist about the ideal technique for culture sample acquisition, which varies with lesion ...
Jason B. Pieper +3 more
wiley +1 more source